All News

Dr Mangat presenting VABS™ at NIC Conference Dr Mangat sharing with the audience at NIC Conference on the rising prevalence of liver disease and how iRnovate's VABS™ could help reshape the future of liver disease diagnostics. At this year’s NIC Conference organised by NUS Medicine International Council, Dr Kamarjit Singh Mangat, Senior Consultant at the Division of Interventional Radiology, Department of Diagnostic Imaging, National University Hospital, delivered a compelling

“There is an urgent need for more accessible, informed screening for cirrhosis in people with MASLD or MASH, as well as the development of better tools to identify patients with MASLD or MASH, who do not have cirrhosis, who could benefit from targeted liver cancer surveillance.” iRnovate is moving into human trials with a low risk liver biopsy tool that provides high quality liver tissue samples for timely diagnosis and intervention. Exciting news that promises to change the

https://www.theguardian.com/society/2025/jun/05/millions-in-west-do-not-know-they-have-aggressive-fatty-liver-disease-study-says

iRnovate Pte. Ltd. signs agreement with NUH and NUS for global exclusive rights to exploit VABS patents

Dr Kam Mangat secures GAP Grant of $260k

https://www.straitstimes.com/singapore/courts-crime/coffee-shop-king-died-of-haemorrhage-after-liver-biopsy-death-a-medical-misadventure

iRnovate Pte. Ltd. incorporated (Singapore) and seed funding secured for animal and FIH trial preparation.

Dr Kam Mangat secures Kickstart Grant of $500k

(only SMART phase $250k used)

approximately S50k used as MERCI disbanded by NUS.